| Product Code: ETC13385551 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Pneumonia Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Pneumonia Vaccine Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Africa Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Africa Pneumonia Vaccine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Africa Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Africa Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.9 Africa Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Africa Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Pneumonia Vaccine Market Trends |
6 Africa Pneumonia Vaccine Market, 2021 - 2031 |
6.1 Africa Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Pneumonia Vaccine Market, Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021 - 2031 |
6.1.3 Africa Pneumonia Vaccine Market, Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021 - 2031 |
6.2 Africa Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Pneumonia Vaccine Market, Revenues & Volume, By Prevnar 13, 2021 - 2031 |
6.2.3 Africa Pneumonia Vaccine Market, Revenues & Volume, By Synflorix, 2021 - 2031 |
6.2.4 Africa Pneumonia Vaccine Market, Revenues & Volume, By Pneumovax 23, 2021 - 2031 |
6.3 Africa Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Pneumonia Vaccine Market, Revenues & Volume, By Public, 2021 - 2031 |
6.3.3 Africa Pneumonia Vaccine Market, Revenues & Volume, By Private, 2021 - 2031 |
6.4 Africa Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Pneumonia Vaccine Market, Revenues & Volume, By Distribution Partner Companies, 2021 - 2031 |
6.4.3 Africa Pneumonia Vaccine Market, Revenues & Volume, By Non-governmental Organizations (NGO), 2021 - 2031 |
6.4.4 Africa Pneumonia Vaccine Market, Revenues & Volume, By Government Authorities, 2020 - 2028 |
7 Africa Pneumonia Vaccine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 South Africa Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 Egypt Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 Nigeria Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.4 Rest of Africa Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 Africa Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
7.3.1 South Africa Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.2 Egypt Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.3 Nigeria Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.4 Rest of Africa Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 Africa Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
7.4.1 South Africa Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
7.4.2 Egypt Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
7.4.3 Nigeria Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
7.4.4 Rest of Africa Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
7.5 Africa Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.1 South Africa Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.2 Egypt Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.3 Nigeria Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.4 Rest of Africa Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Africa Pneumonia Vaccine Market Key Performance Indicators |
9 Africa Pneumonia Vaccine Market - Export/Import By Countries Assessment |
10 Africa Pneumonia Vaccine Market - Opportunity Assessment |
10.1 Africa Pneumonia Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 Africa Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.4 Africa Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
10.5 Africa Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 Africa Pneumonia Vaccine Market - Competitive Landscape |
11.1 Africa Pneumonia Vaccine Market Revenue Share, By Companies, 2022 |
11.2 Africa Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here